Intrinsic enzymes of high-density lipoprotein

被引:3
作者
Le, Ngoc-Anh [1 ]
Walter, Mary F. [1 ]
机构
[1] Emory Univ, Emory Lipid Res Lab, Sch Med, Atlanta Vet Affairs Med Ctr, Decatur, GA 30033 USA
关键词
CETP; Enzymes; GPx; HDL; Inflammation; LCAT; Lp-PLA2; Oxidation; PUP; PON1; Reverse cholesterol transport; CHOLESTERYL-ESTER TRANSFER; PHOSPHOLIPID TRANSFER PROTEIN; PLATELET-ACTIVATING-FACTOR; CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; LIPID TRANSFER PROTEIN; FACTOR ACETYLHYDROLASE; SERUM PARAOXONASE; TRANSGENIC MICE; HUMAN-PLASMA;
D O I
10.1016/j.jacl.2007.01.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several lines of evidence are available to support the protective effects of high-density lipoproteins (HDL) on atherosclerosis. The exact mechanisms by which HDL protects against atherosclerotic disease development are not understood. In addition to its role in the reverse transport of cholesterol from the peripheral sites to the liver for excretion, HDL also carries a number of enzymes that contribute to the remodeling of plasma lipoproteins and to the protection of other lipoproteins against oxidative modification. Many of these enzymes can play a role in determining the composition of circulating HDL, while others appear to affect specific biologic activities associated with HDL. It is not clear whether the concentrations of HDL particles or the activities associated with this class of particles are more important. One of the problems is that HDL constitutes a heterogeneous population of particles, and analytical tools to characterize the various subpopulations are not widely available. In this article, we will review the enzymes that are associated with plasma HDL and possible mechanisms as to how these may contribute to the protective properties of HDL in humans. (C) 2007 National Lipid Association. All rights reserved.
引用
收藏
页码:20 / 30
页数:11
相关论文
共 106 条
[1]  
Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825
[2]   Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma [J].
Asano, K ;
Okamoto, S ;
Fukunaga, K ;
Shiomi, T ;
Mori, T ;
Iwata, M ;
Ikeda, Y ;
Yamaguchi, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) :511-514
[3]   Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial [J].
Asztalos, BF ;
Collins, D ;
Cupples, LA ;
Demissie, S ;
Horvath, KV ;
Bloomfield, HE ;
Robins, SJ ;
Schaefer, EJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) :2185-2191
[4]   Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities - Selective action of human paraoxonase allozymes Q and R [J].
Aviram, M ;
Billecke, S ;
Sorenson, R ;
Bisgaier, C ;
Newton, R ;
Rosenblat, M ;
Erogul, J ;
Hsu, C ;
Dunlop, C ;
La Du, B .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) :1617-1624
[5]  
BAGDADE JD, 1990, J LIPID RES, V31, P1263
[6]   ACCELERATED CHOLESTERYL ESTER TRANSFER IN PLASMA OF PATIENTS WITH HYPERCHOLESTEROLEMIA [J].
BAGDADE, JD ;
RITTER, MC ;
SUBBAIAH, PV .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (04) :1259-1265
[7]   Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study [J].
Ballantyne, CM ;
Hoogeveen, RC ;
Bang, H ;
Coresh, J ;
Folsom, AR ;
Heiss, G ;
Sharrett, AR .
CIRCULATION, 2004, 109 (07) :837-842
[8]  
BANKA CL, 1991, J BIOL CHEM, V266, P23886
[9]   INVITRO EXCHANGES OF ESTERIFIED CHOLESTEROL BETWEEN SERUM LIPOPROTEIN FRACTIONS - STUDIES OF HUMANS AND RABBITS [J].
BARTER, PJ ;
LALLY, JI .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (03) :230-236
[10]   Comparing lives [J].
Barth, F .
FEMINIST ECONOMICS, 1999, 5 (02) :95-98